BIS vs. QTAP
BIS (ProShares UltraShort Nasdaq Biotechnology) and QTAP (Innovator Growth Accelerated Plus ETF - April) are both Leveraged Equities funds. BIS is passively managed, while QTAP is actively managed. Over the past 5 years, BIS returned -14.70%/yr vs 12.65%/yr for QTAP. At a correlation of -0.50, they often move in opposite directions. BIS charges 0.95%/yr vs 0.79%/yr for QTAP.
Performance
BIS vs. QTAP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIS achieves a -17.93% return, which is significantly lower than QTAP's 12.83% return.
BIS
- 1D
- -1.74%
- 1M
- -10.00%
- YTD
- -17.93%
- 6M
- -14.94%
- 1Y
- -55.93%
- 3Y*
- -24.98%
- 5Y*
- -14.70%
- 10Y*
- -26.06%
QTAP
- 1D
- -1.14%
- 1M
- -0.91%
- YTD
- 12.83%
- 6M
- 13.01%
- 1Y
- 22.41%
- 3Y*
- 19.78%
- 5Y*
- 12.65%
- 10Y*
- —
BIS vs. QTAP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | -17.93% | -45.95% | 4.79% | -6.54% | -2.14% | -10.96% |
QTAP Innovator Growth Accelerated Plus ETF - April | 12.83% | 19.36% | 17.34% | 43.32% | -25.87% | 15.95% |
Correlation
The correlation between BIS and QTAP is -0.32, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.39 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.50 |
Correlation (All Time) Calculated using the full available price history since Apr 1, 2021 | -0.50 |
The correlation between BIS and QTAP shifts across timeframes, from -0.50 (all time) to -0.32 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIS vs. QTAP — Risk / Return Rank
BIS
QTAP
BIS vs. QTAP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and Innovator Growth Accelerated Plus ETF - April (QTAP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIS | QTAP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -5.08 | ||
| Sortino ratioReturn per unit of downside risk | -8.36 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 1.94 | -1.19 |
| Calmar ratioReturn relative to maximum drawdown | -1.02 | 9.04 | -10.06 |
| Martin ratioReturn relative to average drawdown | -1.39 | 52.85 | -54.23 |
Loading charts...
Drawdowns
BIS vs. QTAP - Drawdown Comparison
The maximum BIS drawdown since its inception was -99.87%, which is greater than QTAP's maximum drawdown of -29.44%. Use the drawdown chart below to compare losses from any high point for BIS and QTAP.
Loading charts...
Drawdown Indicators
| BIS | QTAP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.87% | -29.44% | -70.43% |
Max Drawdown (1Y)Largest decline over 1 year | -55.07% | -2.49% | -52.58% |
Max Drawdown (3Y)Largest decline over 3 years | -67.92% | -13.03% | -54.89% |
Max Drawdown (5Y)Largest decline over 5 years | -75.59% | -29.44% | -46.15% |
Max Drawdown (10Y)Largest decline over 10 years | -95.40% | — | — |
Current DrawdownCurrent decline from peak | -99.87% | -1.70% | -98.17% |
Average DrawdownAverage peak-to-trough decline | -90.04% | -4.99% | -85.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 41.32% | 0.43% | +40.89% |
Volatility
BIS vs. QTAP - Volatility Comparison
ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 13.79% compared to Innovator Growth Accelerated Plus ETF - April (QTAP) at 3.03%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than QTAP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIS | QTAP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.79% | 3.03% | +10.76% |
Volatility (6M)Calculated over the trailing 6-month period | 32.10% | 4.94% | +27.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.51% | 6.12% | +34.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.80% | 18.92% | +24.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.26% | 18.72% | +27.54% |
BIS vs. QTAP - Expense Ratio Comparison
BIS has a 0.95% expense ratio, which is higher than QTAP's 0.79% expense ratio.
Dividends
BIS vs. QTAP - Dividend Comparison
BIS's dividend yield for the trailing twelve months is around 5.61%, while QTAP has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 5.61% | 5.25% | 3.73% | 1.75% | 0.00% | 0.00% | 0.45% | 2.11% | 0.37% |
QTAP Innovator Growth Accelerated Plus ETF - April | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BIS and QTAP have a correlation of -0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIS has higher volatility (13.79%) compared to QTAP (3.03%). In terms of maximum drawdown, BIS dropped -99.87% vs QTAP's -29.44%.
On 5-year performance, QTAP leads with 12.65% vs -14.70% for BIS. On fees, QTAP is cheaper at 0.79% per year. On volatility, QTAP has been the lower-risk option at 3.03%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, QTAP has performed better with a 12.65% return vs -14.70%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
QTAP is cheaper with a 0.79% expense ratio, compared with 0.95% for BIS.
BIS has the higher dividend yield at 5.61%, compared with 0.00% for QTAP.
They also come from different issuers: ProShares and Innovator. Their fees differ too: 0.95% for BIS and 0.79% for QTAP.
QTAP currently has the higher Sharpe Ratio (3.70 vs -1.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIS and QTAP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer